Quantitative analyses of DAPK1 methylation in AML and MDS
International Journal of Cancer, 09/19/2011Claus R et al.
DAPK1 methylation analysis in a large representative patient cohort of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) patients proofing almost complete absence of elevated DNA methylation. The results highlight the importance of quantitative measurements particularly for translational research questions on primary patient specimens.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.